Synthesis and biological evaluation of novel aliphatic amido-quaternary ammonium salts for anticancer chemotherapy: Part II
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Jee Sun | - |
dc.contributor.author | Song, Doona | - |
dc.contributor.author | Ko, Won Jin | - |
dc.contributor.author | Kim, Bunyea | - |
dc.contributor.author | Kim, Bo-Kyung | - |
dc.contributor.author | Park, Song-Kyu | - |
dc.contributor.author | Won, Misun | - |
dc.contributor.author | Lee, Kiho | - |
dc.contributor.author | Lee, Kyeong | - |
dc.contributor.author | Kim, Hwan Mook | - |
dc.contributor.author | Han, Gyoonhee | - |
dc.date.available | 2020-02-28T23:46:57Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2013-05 | - |
dc.identifier.issn | 0223-5234 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/14558 | - |
dc.description.abstract | A series of novel aliphatic amido-quaternary ammonium salts were synthesized and evaluated for their anticancer effects involving induction of RhoB. Most of these compounds, featuring open-ring forms of aliphatic amido-quaternary ammonium salts, exhibited potent anti-proliferative activities in human cancer cell lines, including PC-3, NUGC-3, MDA-MB-231, ACHN, HCT-15, and NCI-H23. In further evaluation, the representative compound N,N-diethyl-N-(2-(N-methyltetradecanamido)ethyl)prop-2-en-1-aminium bromide (3b) exhibited potent pro-apoptotic activity, through RhoB activation, in HeLa cells. (C) 2013 Elsevier Masson SAS. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.subject | RHOB EXPRESSION | - |
dc.subject | RAS TRANSFORMATION | - |
dc.subject | PROTEIN-KINASES | - |
dc.subject | HUMAN CANCER | - |
dc.subject | APOPTOSIS | - |
dc.subject | CELLS | - |
dc.subject | INHIBITORS | - |
dc.title | Synthesis and biological evaluation of novel aliphatic amido-quaternary ammonium salts for anticancer chemotherapy: Part II | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000322855400059 | - |
dc.identifier.doi | 10.1016/j.ejmech.2012.12.063 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.63, pp.621 - 628 | - |
dc.identifier.scopusid | 2-s2.0-84875932912 | - |
dc.citation.endPage | 628 | - |
dc.citation.startPage | 621 | - |
dc.citation.title | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.volume | 63 | - |
dc.contributor.affiliatedAuthor | Kim, Hwan Mook | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Aliphatic amido-quaternary ammonium salts | - |
dc.subject.keywordAuthor | Open-ring form of aliphatic amido-quaternary ammonium salts | - |
dc.subject.keywordAuthor | RhoB | - |
dc.subject.keywordAuthor | GTPase RAt Sarcoma (Ras) | - |
dc.subject.keywordAuthor | Perifosine | - |
dc.subject.keywordAuthor | NSC126188 | - |
dc.subject.keywordPlus | RHOB EXPRESSION | - |
dc.subject.keywordPlus | RAS TRANSFORMATION | - |
dc.subject.keywordPlus | PROTEIN-KINASES | - |
dc.subject.keywordPlus | HUMAN CANCER | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | INHIBITORS | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.